Clinical Trials Sponsored by Gene PreDiT

Total 583 results

Gene PreDiT
Blueclinical, Ltd.

Terminated

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects (GPD-01-01)

Obesity

Portugal
University Hospital, Bordeaux
PREDIT Go4

Completed

Chronic Sleep Restriction and Driving (PRIVASOM)

Sleep Deprivation

France
Credit Valley EyeCare

Completed

Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome

Glaucoma

Canada
Credit Valley EyeCare

Completed

Dysphotopsia Following Laser Peripheral Iridotomy

Narrow Angle Patients at Risk for Angle Closure Glaucoma

Canada
Gene Solutions

Recruiting

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Non Small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Stage IIIC Non-Small Cell Lung Cancer | Tyrosine Kinase Inhibitors

Vietnam
Gene Solutions

Recruiting

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Breast Cancer | Gastric Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Advanced Cancer | Liver Cancer | Immune Checkpoint Inhibitor

Vietnam
Gene Solutions

Recruiting

Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast Cancer

Vietnam
Premia Spine

Unknown

Post-market Study of the TOPS™ System

Lumbar Spinal Stenosis | Spondylolisthesis

United Kingdom
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT

Alzheimer Disease

Colombia
Sio Gene Therapies

Terminated

Study of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's Disease (SUNRISE-PD)

Parkinson Disease

United Kingdom, France
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT

Aging

Colombia
Libella Gene Therapeutics

Unknown

Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT

Critical Limb Ischemia

Colombia
Gene Surgery LLC

Recruiting

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Melanoma | Sarcoma | Uterine Cervical Neoplasms | Breast Neoplasms | Squamous Cell Carcinoma of Head and Neck | Vulvar Neoplasms | Anus Neoplasms | Penile Neoplasms

Russian Federation
Premia Spine

Active, not recruiting

A Pivotal Study of the Premia Spine TOPS™ System

Lumbar Spinal Stenosis | Degenerative Spondylolisthesis

United States
Premia Spine

Unknown

Post-market Study of the TOPS™ System (TOPS)

Lumbar Spinal Stenosis | Spondylolisthesis

United Kingdom
Credit Valley Rheumatology
Delivra, Inc.

Terminated

Delivra-Celecoxib 8% Cream and Osteoarthritis

Osteoarthritis, Knee

Canada
Dhurakij Pundit University

Not yet recruiting

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

Dyslipidemias | Hypercholesterolemia | Hypertriglyceridemia | Postmenopausal Symptoms | Hyper-LDL-cholesterolemia | Hypo HDL Cholesterolaemia
Taysha Gene Therapies, Inc.

Withdrawn

A Study of the Natural Course of SURF1 Deficiency

Leigh Syndrome

United States
Novartis Gene Therapies

Terminated

Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy (STRONG)

Spinal Muscular Atrophy

United States
Novartis Gene Therapies

Completed

Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1

Spinal Muscular Atrophy 1

United States
Novartis Gene Therapies

Completed

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STR1VE)

Gene Therapy | SMA - Spinal Muscular Atrophy

United States
Novartis Gene Therapies

Completed

Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 (STRIVE-EU)

SMA

France, United Kingdom, Italy, Belgium
Taysha Gene Therapies, Inc.

Recruiting

Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)

Rett Syndrome

United States, United Kingdom
Taysha Gene Therapies, Inc.

Recruiting

Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study)

Rett Syndrome

United States, Canada
Novartis Gene Therapies

Active, not recruiting

Long-Term Follow-up Study for Patients From AVXS-101-CL-101 (START)

Spinal Muscular Atrophy 1

United States
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
GENGE

Recruiting

GENETIC VARIABILITY TO GLP1 TREATMENT (GLP1 treatment)

Obesity | Type 2 Diabetes

Israel
Dhurakij Pundit University

Active, not recruiting

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

Enlarged Pores

Thailand
American Gene Technologies International Inc.

Unknown

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

HIV Infections

United States
Imperial College London
Gene Logic

Completed

Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary Disease

Emphysema | COPD

United Kingdom
American Gene Technologies International Inc.

Completed

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

HIV

United States
American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
American Gene Technologies International Inc.

Enrolling by invitation

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

HIV

United States
Credit Valley EyeCare
Canadian Glaucoma Clinical Research Council

Unknown

Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves

Glaucoma

Canada
PT. Prodia Stem Cell Indonesia

Recruiting

Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis (OA)

Osteoarthritis, Knee

Indonesia
OrbusNeich
Genae

Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT (REMEDEE-OCT)

Coronary Artery Disease | Atherosclerosis | Acute Coronary Syndrome (ACS) | Myocardial Infarction (MI)

United Kingdom, Netherlands, Finland, Belgium, Switzerland
GEn1E Lifesciences

Recruiting

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

Respiratory Distress Syndrome, Acute

United States
GEn1E Lifesciences

Completed

Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GEn1E-1124

Healthy

New Zealand
Geno LLC

Completed

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. (PHiano)

Idiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension

United States
Geno LLC

Withdrawn

Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide (EAGLE)

Pulmonary Arterial Hypertension

United States
Geno LLC

Completed

Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide (PILOT)

Pulmonary Arterial Hypertension

United States
Astellas Gene Therapies

Recruiting

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

Pompe Disease (Late-onset)

United States, Taiwan, France, Spain
iCell Gene Therapeutics
iCar Bio Therapeutics

Recruiting

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

Relapsed/Refractory, High Risk Hematologic Malignancies | T-ALL/Lymphoma

China
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,

Completed

A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

China
Guangzhou Bio-gene Technology Co., Ltd

Active, not recruiting

A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

T-Cell Acute Lymphocytic Leukemia

China
Astellas Gene Therapies

Completed

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects (INCEPTUS)

X-linked Myotubular Myopathy

United States, France, United Kingdom, Canada, Germany
Astellas Gene Therapies

Completed

A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)

Males With X-linked Myotubular Myopathy (XLMTM)

United States, United Kingdom
Axovant Sciences Ltd.

Terminated

Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension

Dementia With Lewy Bodies

United States, Canada, France, Italy, Netherlands, Spain, United Kingdom
Guangzhou Bio-gene Technology Co., Ltd

Not yet recruiting

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Acute Myeloid Leukemia | Leukemia
Guangzhou Bio-gene Technology Co., Ltd

Recruiting

Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

China

Clinical Trials Sponsored by Gene PreDiT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations